牛牛AI助理已提取核心訊息
Connect Biopharma Holdings Limited, a biopharmaceutical company, has filed an amended Schedule 13G/A with the Securities and Exchange Commission on February 13, 2024, indicating changes in ownership by significant shareholders. The filing reveals that BioFortune Inc., based in the British Virgin Islands, and Wubin Pan, a Canadian citizen, have reported beneficial ownership of the company's ordinary shares. As of December 31, 2023, BioFortune Inc. owns 6,158,016 ordinary shares, representing 11.2% of the class, while Wubin Pan has a beneficial ownership of 6,728,292 ordinary shares, or 12.1% of the class. The ownership includes shares held directly by BioFortune Inc., shares underlying stock options held by Pan that are exercisable as of March 1, 2024, and shares held by Pan's spouse. Wubin Pan, who is the sole shareholder of BioFortune Inc., may be deemed to share beneficial ownership of the securities held by BioFortune Inc. The total number of ordinary shares outstanding for Connect Biopharma as of the reporting date was 55,102,954.
Connect Biopharma Holdings Limited, a biopharmaceutical company, has filed an amended Schedule 13G/A with the Securities and Exchange Commission on February 13, 2024, indicating changes in ownership by significant shareholders. The filing reveals that BioFortune Inc., based in the British Virgin Islands, and Wubin Pan, a Canadian citizen, have reported beneficial ownership of the company's ordinary shares. As of December 31, 2023, BioFortune Inc. owns 6,158,016 ordinary shares, representing 11.2% of the class, while Wubin Pan has a beneficial ownership of 6,728,292 ordinary shares, or 12.1% of the class. The ownership includes shares held directly by BioFortune Inc., shares underlying stock options held by Pan that are exercisable as of March 1, 2024, and shares held by Pan's spouse. Wubin Pan, who is the sole shareholder of BioFortune Inc., may be deemed to share beneficial ownership of the securities held by BioFortune Inc. The total number of ordinary shares outstanding for Connect Biopharma as of the reporting date was 55,102,954.
生物製藥公司Connect Biopharma Holdings Limited已於2024年2月13日向美國證券交易委員會提交了經修訂的附表13G/A，表明大股東的所有權發生了變化。該文件顯示，總部位於英屬維爾京群島的BioFortune Inc.和加拿大公民Wubin Pan已報告了該公司普通股的實益所有權。截至2023年12月31日，BioFortune Inc.擁有6,158,016股普通股，佔該類別的11.2％，而潘武斌擁有6,728,292股普通股的實益所有權，佔該類別的12.1％。所有權包括BioFortune Inc. 直接持有的股份、自2024年3月1日起可行使的Pan持有的標的股票期權以及潘的配偶持有的股份。潘武斌是BioFortune Inc.的唯一股東，可能被視爲共享生物財富公司持有的證券的實益所有權。截至報告日，Connect Biopharma的已發行普通股總數爲55,102,954股。
生物製藥公司Connect Biopharma Holdings Limited已於2024年2月13日向美國證券交易委員會提交了經修訂的附表13G/A，表明大股東的所有權發生了變化。該文件顯示，總部位於英屬維爾京群島的BioFortune Inc.和加拿大公民Wubin Pan已報告了該公司普通股的實益所有權。截至2023年12月31日，BioFortune Inc.擁有6,158,016股普通股，佔該類別的11.2％，而潘武斌擁有6,728,292股普通股的實益所有權，佔該類別的12.1％。所有權包括BioFortune Inc. 直接持有的股份、自2024年3月1日起可行使的Pan持有的標的股票期權以及潘的配偶持有的股份。潘武斌是BioFortune Inc.的唯一股東，可能被視爲共享生物財富公司持有的證券的實益所有權。截至報告日，Connect Biopharma的已發行普通股總數爲55,102,954股。
有用
沒用